Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Byun, W. M. Articles by Frahm, J. Search for Related Content PubMed PubMed Citation Articles by Byun, W. M. Articles by Frahm, J.

American Journal of Neuroradiology 23:906-912, June-July 2002
© 2002 American Society of Neuroradiology

SPINE

Diffusion-Weighted MR Imaging of Metastatic Disease of the Spine: Assessment of Response to Therapy

Woo Mok Byun^a, Sei One Shin^b, Yongmin Chang^c, Sang Jin Lee^d, Jurgen Finsterbusch^e and Jens Frahm^e

^a Department of Diagnostic Radiology College of Medicine, Yeungnam University, Daegu, Korea
^b Therapeutic Radiology and Oncology, College of Medicine, Yeungnam University, Daegu, Korea
^c Department of Diagnostic Radiology, College of Medicine, Kyungpook National University, Daegu, Korea
^d Department of Diagnostic Radiology, College of Medicine, Soonchunhyang University, Gumi, Korea
^e Biomedizinische NMR Forschungs GmbH, Gottingen, Germany

Address reprint requests to Woo Mok Byun, MD, Department of Diagnostic Radiology, College of Medicine, Yeungnam University, 317–1, Daemyungdong, Namku, Daegu 705–717, Korea

BACKGROUND AND PURPOSE: In cases of metastatic disease of the spine, monitoring the response to medical therapy with plain radiography, bone scanning, and conventional spin-echo sequence MR imaging is unsatisfactory because of the insensitivity or nonspecific findings of these imaging modalities. The purpose of this study was to investigate signal intensity changes of bone marrow after therapy by using diffusion-weighted MR imaging to monitor the response to medical therapy in cases of metastatic disease of the spine.

METHODS: Twenty-four patients with metastatic disease of the spine were examined with MR imaging. Diffusion-weighted MR imaging and spin-echo MR imaging were performed in all patients before and after radiation therapy. Follow-up diffusion-weighted MR imaging and spin-echo MR imaging were performed for comparison purposes in nine cases at 1 month, in seven cases at 2 months, in seven cases at 3 months, and in three cases at 6 months after therapy. The diffusion-weighted MR imaging sequences were based on a steady-state free precession with a low b value (165 s/mm²) and a single shot stimulated echo-acquisition mode with a high b value (650 s/mm²). Apparent diffusion coefficient maps were obtained using two different b values incorporated in a diffusion-weighted single shot stimulated echo-acquisition mode sequence. Apparent diffusion coefficient maps were obtained in three cases. Signal intensity changes of the metastatic disease of the vertebral bone marrow before and after therapy on conventional spin-echo sequence and diffusion-weighted MR images were evaluated.

RESULTS: As shown by diffusion-weighted MR imaging, metastatic disease of the vertebral bone marrow included in our study before therapy was hyperintense to normal vertebral bodies. In 23 patients with clinical improvement, metastatic disease of the spine after therapy was hypointense relative to normal vertebral bodies on the follow-up diffusion-weighted MR images. In one patient with hepatocellular carcinoma, the clinical symptoms did not improve and follow-up bone scanning performed 6 months after therapy showed increased uptake. Persistent hyperintense bone marrow after therapy was also noted on diffusion-weighted MR images. Decreased signal intensity of the metastatic disease of the spine on diffusion-weighted MR images was observed >1 month after therapy.

CONCLUSION: Diffusion-weighted MR imaging shows that, with successful therapy, there is decreased signal intensity of metastatic disease of the vertebral bone marrow.

This article has been cited by other articles:

				D. A. Hamstra, A. Rehemtulla, and B. D. Ross Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology J. Clin. Oncol., September 10, 2007; 25(26): 4104 - 4109. [Abstract] [Full Text] [PDF]

				A.J. Nemeth, J.W. Henson, M.E. Mullins, R.G. Gonzalez, and P.W. Schaefer Improved Detection of Skull Metastasis with Diffusion-Weighted MR Imaging AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1088 - 1092. [Abstract] [Full Text] [PDF]

				D.-M. Koh and D. J. Collins Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology Am. J. Roentgenol., June 1, 2007; 188(6): 1622 - 1635. [Abstract] [Full Text] [PDF]

				M. Maeda, H. Sakuma, S. E. Maier, and K. Takeda Quantitative Assessment of Diffusion Abnormalities in Benign and Malignant Vertebral Compression Fractures by Line Scan Diffusion-Weighted Imaging Am. J. Roentgenol., November 1, 2003; 181(5): 1203 - 1209. [Abstract] [Full Text] [PDF]

				M. Castillo Diffusion-Weighted Imaging of the Spine: Is It Reliable? AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1251 - 1253. [Full Text] [PDF]